BioCentury | Feb 18, 2013
Finance

Jouncing immunotherapy

...University 's Lombardi Comprehensive Cancer Center. Pardoll invented the GVAX cancer vaccines initially developed by Somatix Therapy Corp....
BioCentury | Apr 7, 2008
Strategy

Takeda fills a gap

...seen," said Masuda. Cell Genesys received the GVAX platform when it acquired Somatix Therapy Corp. in 1997. Somatix...
BioCentury | Dec 4, 2006
Strategy

PER.C6 perseverance

...not thinking beyond that," Valerio said. "In those days the leading gene therapy companies were Somatix...
BioCentury | Sep 20, 1999
Strategy

Somatix lives on

...programs now consist entirely of the GVAX cancer vaccines it acquired through its purchase of Somatix Therapy Corp....
...III depend on data, but also portfolio management." CEGE has made its own portfolio decisions. Somatix...
...lung cancer vaccine. In addition, the combination of CEGE's gene therapy vectors with technology from Somatix...
BioCentury | Apr 26, 1999
Strategy

The spin on spinouts

...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...
...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...
BioCentury | Dec 8, 1997
Company News

Progenitor management update

...Park, Calif. Business: Drug discovery Hired: Lawrence Cohen as COO, formerly VP of R&D at Somatix Therapy Corp....
BioCentury | Dec 8, 1997
Emerging Company Profile

Xenogen: Peering into hidden regions

...Contag said. Contag shares the CEO position with David Carter, former president and CEO of Somatix Therapy Corp....
BioCentury | Jul 7, 1997
Company News

Pangea Pharmaceuticals Inc. management update

...Ph.D., as VP of product development; formerly VP of regulatory, quality and clinical affairs at Somatix Therapy Corp. WIR...
BioCentury | Jun 16, 1997
Analyst Picks & Changes

Analyst picks & changes

...Angus Macdonald began coverage with a "buy" and a $10 target. The recent acquisition of Somatix Therapy Corp....
BioCentury | Jun 9, 1997
Company News

Cell Genesys, Somatix deal

...charge related to acquired in-process technology and restructuring. Cell Genesys Inc. (CEGE), Foster City, Calif. Somatix Therapy Corp....
Items per page:
1 - 10 of 75
BioCentury | Feb 18, 2013
Finance

Jouncing immunotherapy

...University 's Lombardi Comprehensive Cancer Center. Pardoll invented the GVAX cancer vaccines initially developed by Somatix Therapy Corp....
BioCentury | Apr 7, 2008
Strategy

Takeda fills a gap

...seen," said Masuda. Cell Genesys received the GVAX platform when it acquired Somatix Therapy Corp. in 1997. Somatix...
BioCentury | Dec 4, 2006
Strategy

PER.C6 perseverance

...not thinking beyond that," Valerio said. "In those days the leading gene therapy companies were Somatix...
BioCentury | Sep 20, 1999
Strategy

Somatix lives on

...programs now consist entirely of the GVAX cancer vaccines it acquired through its purchase of Somatix Therapy Corp....
...III depend on data, but also portfolio management." CEGE has made its own portfolio decisions. Somatix...
...lung cancer vaccine. In addition, the combination of CEGE's gene therapy vectors with technology from Somatix...
BioCentury | Apr 26, 1999
Strategy

The spin on spinouts

...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...
...the core gene therapy area. Finally, CEGE was contemplating an acquisition in gene therapy - Somatix...
BioCentury | Dec 8, 1997
Company News

Progenitor management update

...Park, Calif. Business: Drug discovery Hired: Lawrence Cohen as COO, formerly VP of R&D at Somatix Therapy Corp....
BioCentury | Dec 8, 1997
Emerging Company Profile

Xenogen: Peering into hidden regions

...Contag said. Contag shares the CEO position with David Carter, former president and CEO of Somatix Therapy Corp....
BioCentury | Jul 7, 1997
Company News

Pangea Pharmaceuticals Inc. management update

...Ph.D., as VP of product development; formerly VP of regulatory, quality and clinical affairs at Somatix Therapy Corp. WIR...
BioCentury | Jun 16, 1997
Analyst Picks & Changes

Analyst picks & changes

...Angus Macdonald began coverage with a "buy" and a $10 target. The recent acquisition of Somatix Therapy Corp....
BioCentury | Jun 9, 1997
Company News

Cell Genesys, Somatix deal

...charge related to acquired in-process technology and restructuring. Cell Genesys Inc. (CEGE), Foster City, Calif. Somatix Therapy Corp....
Items per page:
1 - 10 of 75